Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CIS-DIAMMINEDICHLOROPLATINUM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1272 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Steer, C; Harper, P
      Is there any place for cytotoxic chemotherapy in endometrial cancer?

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    2. Cham, ST; Diakos, CI; Ellis, LT; Fenton, RR; Munk, VP; Messerle, BA; Hambley, TW
      Isomer formation in the binding of [PtCl2(cis-cyclohexane-1,3-diamine)] tooligonucleotides and the X-ray crystal structure of [PtCl2(cis-cyclohexane-1,3-diamine)]center dot dimethylformamide

      JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS
    3. Tsipis, AC; Katsoulos, GA
      Conformational preferences, rotational barriers and energetics of purine nucleobase rotation and dissociation in square planar platinum(II) antitumour complexes: Structure-activity correlation

      PHYSICAL CHEMISTRY CHEMICAL PHYSICS
    4. Mendelsohn, J
      The epidermal growth factor receptor as a target for cancer therapy

      ENDOCRINE-RELATED CANCER
    5. Basu, A; Woolard, MD; Johnson, CL
      Involvement of protein kinase C-delta in DNA damage-induced apoptosis

      CELL DEATH AND DIFFERENTIATION
    6. Veal, GJ; Dias, C; Price, L; Parry, A; Errington, J; Hale, J; Pearson, ADJ; Boddy, AV; Newell, DR; Tilby, MJ
      Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy

      CLINICAL CANCER RESEARCH
    7. Kanzawa, F; Koizumi, F; Koh, Y; Nakamura, T; Tatsumi, Y; Fukumoto, H; Saijo, N; Yoshioka, T; Nishio, K
      In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction

      CLINICAL CANCER RESEARCH
    8. Kusunoki, N; Ku, Y; Tominaga, M; Iwasaki, T; Fukumoto, T; Muramatsu, S; Sugimoto, T; Tsuchida, S; Takamatsu, M; Suzuki, Y; Kuroda, Y
      Effect of sodium thiosulfate on cisplatin removal with complete hepatic venous isolation and extracorporeal charcoal hemoperfusion: A pharmacokineticevaluation

      ANNALS OF SURGICAL ONCOLOGY
    9. Ganaha, F; Yamada, T; Ujita, M; Irie, T; Fukuda, Y; Fukuda, K
      Intraarterial low-dose cisplatin via an indwelling port and concurrent radiotherapy for invasive bladder cancer

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    10. Antunes, LMG; Darin, JDAC; Bianchi, MDP
      Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats

      PHARMACOLOGICAL RESEARCH
    11. Francescato, HD; Costa, RS; Mafalda, S; Camargo, R; Zanetti, MA; Lavrador, MA; Bianchi, MDP
      Effect of oral selenium administration on cisplatin-induced nephrotoxicityin rats

      PHARMACOLOGICAL RESEARCH
    12. Airoldi, M; De Stefani, A; Marchionatti, S; Pedani, F; Gabriele, P; Ragona, R; Cortesina, G; Bumma, C
      Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    13. Jin, SG; Choi, JH; Ahn, B; O'Connor, TR; Mar, W; Lee, CS
      Excision repair of adozelesin-N3 adenine adduct by 3-methyladenine-DNA glycosylases and UVrABC nuclease

      MOLECULES AND CELLS
    14. Cemazar, M; Miklavcic, D; Mir, LM; Belchradek, J; Bonnay, M; Fourcault, D; Sersa, G
      Electrochemotherapy of tumours resistant to cisplatin: a study in a murinetumour model

      EUROPEAN JOURNAL OF CANCER
    15. Schellens, JHM; Planting, AST; Ma, J; Maliepaard, M; de Vos, A; Dennert, MD; Verweij, J
      Adaptive intrapatient dose escalation of cisplatin in patients with advanced head and neck cancer

      ANTI-CANCER DRUGS
    16. Sugimoto, T; Takeyama, A; Fujita, M; Ichikawa, H; Takano-Yamamoto, T
      Peripheral neuroglial death induced by cisplatin administration in newbornrats

      NEUROREPORT
    17. Hambley, TW; Ling, ECH; Munk, VP; Davies, MS
      Steric control of stereoselective interactions between the platinum(II) complex [PtCl2(1,4-diazacycloheptane)] and DNA: comparison with cis-[PtCl2(NH3)(2)] and [PtCl2(ethane-1,2-diamine)] using DNA binding and molecular modeling studies

      JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
    18. Hahn, M; Kleine, M; Sheldrick, WS
      Interaction of cisplatin with methionine- and histidine-containing peptides: competition between backbone binding, macrochelation and peptide cleavage

      JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
    19. Malina, J; Novakova, O; Keppler, BK; Alessio, E; Brabec, V
      Biophysical analysis of natural, double-helical DNA modified by anticancerheterocyclic complexes of ruthenium(lll) in cell-free media

      JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
    20. Heudi, O; Brisset, H; Cailleux, A; Allain, P
      Chemical instability and methods for measurement of cisplatin adducts formed by interactions with cysteine and glutathione

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    21. Hann, S; Zenker, A; Galanski, M; Bereuter, TL; Stingeder, G; Keppler, BK
      HPIC-UV-ICP-SFMS study of the interaction of cisplatin with guanosine monophosphate

      FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY
    22. Warashina, T; Hoshino, H; Yotsuyanagi, T
      Successive determinations of platinum(II) and selenium(IV) with 1,4-dibromo-2,3-diaminonaphthalene in aqueous micellar solutions

      ANALYTICAL SCIENCES
    23. Nakamura, T; Koizumi, F; Kaneko, N; Tamura, T; Chiwaki, F; Koh, Y; Akutagawa, S; Saijo, N; Nishio, K
      Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519

      JAPANESE JOURNAL OF CANCER RESEARCH
    24. Rooseboom, M; Commandeur, JNM; Floor, GC; Rettie, AE; Vermeulen, NPE
      Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates

      CHEMICAL RESEARCH IN TOXICOLOGY
    25. Feyerabend, T; Wiedemann, GJ; Jager, B; Vesely, H; Mahlmann, B; Richter, E
      Local hyperthermia, radiation, and chemotherapy in recurrent breast canceris feasible and effective except for inflammatory disease

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    26. Amtmann, E; Zoller, M; Wesch, H; Schilling, G
      Antitumoral activity of a sulphur-containing platinum complex with an acidic pH optimum

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    27. Kawanishi, K; Miyagi, Y; Yamamoto, J; Miyagi, Y; Nakamura, K; Kodama, J; Hongo, A; Yoshinouchi, M; Kudo, T
      Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    28. Miyagi, Y; Kawanishi, K; Miyagi, Y; Yamada, S; Yamamoto, J; Kodama, J; Hongo, A; Yoshinouchi, M; Kudo, T
      Cytocidal effect and DNA damage of nedaplatin: a mathematical model and analysis of experimental data

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    29. Hofr, C; Farrell, N; Brabec, V
      Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex

      NUCLEIC ACIDS RESEARCH
    30. Nishikawa, M; Nagatomi, H; Nishijima, M; Ohira, G; Chang, BJ; Sato, E; Inoue, M
      Targeting superoxide dismutase to renal proximal tubule cells inhibits nephrotoxicity of cisplatin and increases the survival of cancer-bearing mice

      CANCER LETTERS
    31. Son, KK; Rosenblatt, J
      Overexpression of protein kinase A-RI alpha reduces lipofection efficiencyof cisplatin-resistant human tumor cells

      CANCER LETTERS
    32. Smith, PC; Keller, ET
      Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice

      PROSTATE
    33. Lee, GY; Jun, MS
      DFT studies on binding of Pt(NH3)(2)Cl+ to guanine

      BULLETIN OF THE KOREAN CHEMICAL SOCIETY
    34. Tanaka, T; Masuda, H; Naito, M; Tamai, H
      Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line

      ANTICANCER RESEARCH
    35. Swarts, JC; Swarts, DM; Maree, DM; Neuse, EW; La Madeleine, C; Van Lier, JE
      Polyaspartamides as water-soluble drug carriers. Part 1: Antineoplastic activity of ferrocene-containing polyaspartamide conjugates

      ANTICANCER RESEARCH
    36. Gangopadhyay, SB; Roendigs, A; Kangarloo, SB; Krebs, B; Wolff, JEA
      Cellular accumulation determines the activity of three novel tricyclic platinum agents

      ANTICANCER RESEARCH
    37. Raaphorst, GP; Cybulski, SE; Sobol, R; Ng, CE
      The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiation

      ANTICANCER RESEARCH
    38. Viale, M; Vannozzi, MO; Mandys, V; Esposito, M
      Time-dependent influence of procaine hydrochloride on cisplatin antitumor activity in p388 tumor bearing mice

      ANTICANCER RESEARCH
    39. Wysokinski, R; Michalska, D
      The performance of different density functional methods in the calculationof molecular structures and vibrational spectra of platinum(II) antitumor drugs: Cisplatin and carboplatin

      JOURNAL OF COMPUTATIONAL CHEMISTRY
    40. Warnke, U; Gysler, J; Hofte, B; Tjaden, UR; van der Greef, J; Kloft, C; Schunack, W; Jaehde, U
      Separation and identification of platinum adducts with DNA nucleotides by capillary zone electrophoresis and capillary zone electrophoresis coupled to mass spectrometry

      ELECTROPHORESIS
    41. Yoon, SS; Ahn, KS; Kim, SH; Shim, YM; Kim, J
      In vitro establishment of cis-diammine-dichloroplatinum(II) resistant lungcancer cell line and modulation of apoptotic gene expression as a mechanism of resistant phenotype

      LUNG CANCER
    42. Wetzel, CC; Berberich, SJ
      p53 binds to cisplatin-damaged DNA

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    43. Kung, A; Strickmann, DB; Galanski, M; Keppler, BK
      Comparison of the binding behavior of oxaliplatin, cisplatin and analoguesto 5 '-GMP in the presence of sulfur-containing molecules by means of capillary electrophoresis and electrospray mass spectrometry

      JOURNAL OF INORGANIC BIOCHEMISTRY
    44. Neault, JF; Benkirane, A; Malonga, H; Tajmir-Riahi, HA
      Interaction of cisplatin drug with Na,K-ATPase: drug binding mode and protein secondary structure

      JOURNAL OF INORGANIC BIOCHEMISTRY
    45. Verstraete, S; Heudi, O; Cailleux, A; Allain, P
      Comparison of the reactivity of oxaliplatin, Pt(diaminocyclohexane)Cl-2 and Pt(diaminocyclohexane(1))(OH2)(2)(2+) with guanosine and L-methionine

      JOURNAL OF INORGANIC BIOCHEMISTRY
    46. Faraglia, G; Fregona, D; Sitran, S; Giovagnini, L; Marzano, C; Baccichetti, F; Casellato, U; Graziani, R
      Platinum(II) and palladium(II) complexes with dithiocarbamates and amines:synthesis, characterization and cell assay

      JOURNAL OF INORGANIC BIOCHEMISTRY
    47. Tulub, AA; Stefanov, VE
      Cisplatin stops tubulin assembly into microtubules. A new insight into themechanism of antitumor activity of platinum complexes

      INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
    48. Futagami, M; Sato, S; Sakamoto, T; Yokoyama, Y; Saito, Y
      Effects of melatonin on the proliferation and cis-diamminedichloroplatinum(CDDP) sensitivity of cultured human ovarian cancer cells

      GYNECOLOGIC ONCOLOGY
    49. Erdlenbruch, B; Nier, M; Kern, W; Hiddemann, W; Pekrun, A; Lakomek, M
      Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatricpatients

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    50. Furuchi, T; Ishikawa, H; Miura, N; Ishizuka, M; Kajiya, K; Kuge, S; Naganuma, A
      Two nuclear proteins, Cin5 and Ydr259c, confer resistance to cisplatin in Saccharomyces cerevisiae

      MOLECULAR PHARMACOLOGY
    51. Mendelsohn, J; Dinney, CPN
      The Willet F. Whitmore, Jr., lectureship: Blockade of epidermal growth factor receptors as anticancer therapy

      JOURNAL OF UROLOGY
    52. Mizutani, Y; Nakao, M; Ogawa, O; Yoshida, O; Bonavida, B; Miki, T
      Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin

      JOURNAL OF UROLOGY
    53. Rolhion, C; Penault-Llorca, F; Kemeny, JL; Lemaire, JJ; Jullien, C; Labit-Bouvier, C; Finat-Duclos, F; Verrelle, P
      Interleukin-6 overexpression as a marker of malignancy in human gliomas

      JOURNAL OF NEUROSURGERY
    54. Ho, YP; To, KKW; Au-Yeung, SCF; Wang, XN; Lin, G; Han, XW
      Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety

      JOURNAL OF MEDICINAL CHEMISTRY
    55. Wei, M; Cohen, SM; Silverman, AP; Lippard, SJ
      Effects of spectator ligands on the specific recognition of intrastrand platinum-DNA cross-links by high mobility group box and TATA-binding proteins

      JOURNAL OF BIOLOGICAL CHEMISTRY
    56. Zehnulova, J; Kasparkova, J; Farrell, N; Brabec, V
      Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464

      JOURNAL OF BIOLOGICAL CHEMISTRY
    57. Kasparkova, J; Pospisilova, S; Brabec, V
      Different recognition of DNA modified by antitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53

      JOURNAL OF BIOLOGICAL CHEMISTRY
    58. Hofr, C; Brabec, V
      Thermal and thermodynamic properties of duplex DNA containing site-specific interstrand cross-link of antitumor cisplatin or its clinically ineffective trans isomer

      JOURNAL OF BIOLOGICAL CHEMISTRY
    59. Hengstler, JG; Pilch, H; Schmidt, M; Dahlenburg, H; Sagemuller, J; Schiffer, I; Oesch, F; Knapstein, PG; Kaina, B; Tanner, B
      Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis

      INTERNATIONAL JOURNAL OF CANCER
    60. Najjar, TAO; Saad, SY
      Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits

      CHEMOTHERAPY
    61. Kobayashi, S; Nakamura, Y; Maehara, T; Hamashima, H; Sasatsu, M; Asano, K; Ohishi, Y; Tanaka, A
      DNA topology on an increase in positive writhing number of DNA: Conformation changes in the time course of cis-diamminedichloroplatinum(II)-DNA adducts

      CHEMICAL & PHARMACEUTICAL BULLETIN
    62. Johnsson, A; Byrne, P; de Bruin, R; Weiner, D; Wong, J; Los, G
      Identification of gene clusters differentially expressed during the cellular injury responses (CIR) to cisplatin

      BRITISH JOURNAL OF CANCER
    63. Redon, S; Bombard, S; Elizondo-Riojas, MA; Chottard, JC
      Platination of the (T(2)G(4))(4) telomeric sequence: A structural and cross-linking study

      BIOCHEMISTRY
    64. Meijer, C; van Luyn, MJA; Nienhuis, EF; Blom, N; Mulder, NH; de Vries, EGE
      Ultrastructural morphology and localisation of cisplatin-induced platinum-DNA adducts in a cisplatin-sensitive and -resistant human small cell lung cancer cell line using electron microscopy

      BIOCHEMICAL PHARMACOLOGY
    65. Hanigan, MH; Lykissa, ED; Townsend, DM; Ou, CN; Barrios, R; Lieberman, MW
      gamma-Glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin

      AMERICAN JOURNAL OF PATHOLOGY
    66. Marzilli, LG; Saad, JS; Kuklenyik, Z; Keating, KA; Xu, YH
      Relationship of solution and protein-bound structures of DNA duplexes withthe major intrastrand cross-link lesions formed on cisplatin binding to DNA

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    67. Blasiak, J; Kowalik, J
      Protective action of vitamin C against DNA damage induced by selenium-cisplatin conjugate

      ACTA BIOCHIMICA POLONICA
    68. Barber, R; Plumb, M; Smith, AG; Cesar, CE; Boulton, E; Jeffreys, AJ; Dubrova, YE
      No correlation between germline mutation at repeat DNA and meiotic crossover in male mice exposed to X-rays or cisplatin

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    69. Choudhury, RC; Jagdale, MB; Misra, S
      Potential transmission of the cytogenetic effects of cisplatin in the malegermline cells of Swiss mice

      JOURNAL OF CHEMOTHERAPY
    70. Choudhury, RC; Jagdale, MB; Misra, S
      Cytogenetic toxicity of cisplatin in bone marrow cells of Swiss mice

      JOURNAL OF CHEMOTHERAPY
    71. Gregus, Z; Gyurasics, A; Csanaky, T
      Effects of arsenic-, platinum- and gold-containing drugs on the disposition of exogenous selenium in rats

      TOXICOLOGICAL SCIENCES
    72. Strawn, LM; Kabbinavar, F; Schwartz, DP; Mann, E; Shawver, LK; Slamon, DJ; Cherrington, JM
      Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts

      CLINICAL CANCER RESEARCH
    73. Mendelsohn, J
      Blockade of receptors for growth factors: An anticancer therapy - The Fourth Annual Joseph H. Burchenal American Association for Cancer Research Clinical Research Award Lecture

      CLINICAL CANCER RESEARCH
    74. Sirotnak, FM; Zakowski, MF; Miller, VA; Scher, HI; Kris, MG
      Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase

      CLINICAL CANCER RESEARCH
    75. Donato, NJ; Perez, M; Kang, H; Siddik, ZH; Ling, YH; Perez-Soler, R
      EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity

      CLINICAL CANCER RESEARCH
    76. Zdraveski, ZZ; Mello, JA; Marinus, MG; Essigmann, JM
      Multiple pathways of recombination define cellular responses to cisplatin

      CHEMISTRY & BIOLOGY
    77. Tulub, AA
      New concept of the mechanism of antitumor activity of cis-dichlorodiammineplatinum(II)

      RUSSIAN JOURNAL OF GENERAL CHEMISTRY
    78. Kokubo, M; Nishimura, Y; Shibamoto, Y; Sasai, K; Hosotani, R; Imamura, M; Hiraoka, M
      Concurrent chemoradiotherapy combined with intraoperative radiotherapy forlocally advanced pancreatic cancer: A feasibility study

      ONCOLOGY REPORTS
    79. Takiuchi, H; Hirata, I; Kawabe, S; Egashira, Y; Katsu, K
      Immunohistochemical expression of vascular endothelial growth factor can predict response to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma

      ONCOLOGY REPORTS
    80. Bando, T; Fujimura, M; Kasahara, K; Ueno, T; Matsuda, T
      Selective beta 2-adrenoceptor agonist enhances sensitivity to cisplatin innon-small cell lung cancer cell line

      ONCOLOGY REPORTS
    81. Yoshida, Y; Hosokawa, K; Dantes, A; Tajima, K; Kotsuji, F; Amsterdam, A
      Theophylline and cisplatin synergize in down regulation of BCL-2 inductionof apoptosis in human granulosa cells transformed by a mutated p53 (p53 va1135) and Ha-ras oncogene

      INTERNATIONAL JOURNAL OF ONCOLOGY
    82. Pak, BJ; Li, Q; Kerbel, RS; Ben-David, Y
      TYRP2-mediated resistance to cis-diamminedichloroplatinum (II) in human melanoma cells is independent of tyrosinase and TYRP1 expression and melanin content

      MELANOMA RESEARCH
    83. Watanabe, K; Yagi, T
      Expression of myeloperoxidase in the inner ear of cisplatin-treated guineapigs

      ANTI-CANCER DRUGS
    84. Watanabe, K; Hess, A; Michel, O; Yagi, T
      Nitric oxide synthase inhibitor reduces the apoptotic change in the cisplatin-treated cochlea of guinea pigs

      ANTI-CANCER DRUGS
    85. Watanabe, K; Hess, A; Bloch, W; Michel, O
      Nitric oxide synthase inhibitor suppresses the ototoxic side effect of cisplatin in guinea pigs

      ANTI-CANCER DRUGS
    86. Hambley, TW; Ling, ECH; O'Mara, S; McKeage, MJ; Russell, PJ
      Increased targeting of adenine-rich sequences by (2-amino-2-methyl 3-butanone oxime)dichloroplatinum(II) and investigations into its low cytotoxicity

      JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
    87. Zenker, A; Galanski, M; Bereuter, TL; Keppler, BK; Lindner, W
      Time-dependent interactions of platinum(II) complexes with 5 '-GMP under simulated physiological conditions studied by capillary electrophoresis

      JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
    88. Brabec, V; Neplechova, K; Kasparkova, J; Farrell, N
      Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups

      JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
    89. Parkinson, JA; Chen, Y; Murdoch, PD; Guo, ZJ; Berners-Price, SJ; Brown, T; Sadler, PJ
      Sequence-dependent bending of DNA induced by cisplatin: NMR structures of an A center dot T-rich 14-mer duplex

      CHEMISTRY-A EUROPEAN JOURNAL
    90. Legendre, F; Bas, V; Kozelka, J; Chottard, JC
      A complete kinetic study of GG versus AG platination suggests that the doubly aquated derivatives of cisplatin are the actual DNA binding species

      CHEMISTRY-A EUROPEAN JOURNAL
    91. Wozniak, K; Walter, Z
      Induction of DNA-protein cross-links by platinum compounds

      ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES
    92. Tsai, CM; Chang, KT; Li, L; Perng, RP; Yang, LY
      Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    93. Kishimoto, S; Miyazawa, K; Terakawa, Y; Ashikari, H; Ohtani, A; Fukushima, S; Takeuchi, Y
      Cytotoxicity of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N ')bis(myristato)]-platinum (II) suspended in lipiodol in a newly established cisplatin-resistant rat hepatoma cell line

      JAPANESE JOURNAL OF CANCER RESEARCH
    94. Cui, W; Yazlovitskaya, EM; Mayo, MS; Pelling, JC; Persons, DL
      Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal-regulated protein kinases 1 and 2 in a series of cisplatin-resistantovarian carcinoma cell lines

      MOLECULAR CARCINOGENESIS
    95. Farah, N; Dresner, HS; Searles, KJ; Winiarsky, R; Moosikasuwan, M; Cajigas, A; Hahm, S; Steinberg, JJ
      Cisplatin DNA adduct detection and depurination measured by P-32 DNA radiolabeling and two-dimensional thin-layer chromatography: A time and concentration study

      CANCER INVESTIGATION
    96. Jeremic, B; Shibamoto, Y; Milicic, B; Nikolic, N; Dagovic, A; Aleksandrovic, J; Vaskovic, Z; Tadic, L
      Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial

      JOURNAL OF CLINICAL ONCOLOGY
    97. Nagourney, RA; Link, JS; Blitzer, JB; Forsthoff, C; Evans, SS
      Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    98. Tsukasaki, N; Whitworth, CA; Rybak, LP
      Acute changes in cochlear potentials due to cisplatin

      HEARING RESEARCH
    99. Cardinaal, RM; de Groot, JCMJ; Huizing, EH; Veldman, JE; Smoorenburg, GF
      Cisplatin-induced ototoxicity: Morphological evidence of spontaneous outerhair cell recovery in albino guinea pigs?

      HEARING RESEARCH
    100. Cardinaal, RM; de Groot, JCMJ; Huizing, EH; Veldman, JE; Smoorenburg, GF
      Histological effects of co-administration of an ACTH((4-9)) analogue, ORG 2766, on cisplatin ototoxicity in the albino guinea pig

      HEARING RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 19:48:50